{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:28:22Z","timestamp":1787761702331,"version":"build-2784847793"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The characteristics of premature infants vary from country to country rendering it challenging to apply retinopathy of prematurity (ROP) screening algorithm globally. The screening criteria for postnatal growth and ROP (G-ROP) for preterm infants are known to be beneficial, but it is not clear whether these criteria can be used universally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The aim of this study is to validate the accuracy of the G-ROP criteria in screening preterm infants in Saudi Arabia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>This single-center retrospective study included 300 premature infants (mean gestational age [GA], 28.72 \u00b1 2.2 weeks; range, 21\u201336 weeks) at a referral center who were screened for ROP between 2015 and 2021. The inclusion criteria were the availability of data on ROP outcome and body weight up until day 40 after birth. The G-ROP 1 and G-ROP 2 models were examined for their ability and accuracy in identifying infants with any stage ROP and treatable ROP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The G-ROP 1 and G-ROP 2 models identified 233 and 255 infants for screening, respectively. The sensitivity of G-ROP 1 and G-ROP 2 for detecting treated ROP was 96.7% and 100%, respectively, and the specificity for detecting treatable ROP was 24.4% and 16.7%, respectively. Incorporation of the G-ROP 2 model, which did not miss any infant with type 1 ROP, would have reduced the number of screened infants by 15%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>G-ROP 2 was more sensitive than G-ROP 1 for identifying infants who required treatment and could potentially reduce the burden of ROP screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_523_22","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T03:32:22Z","timestamp":1677641542000},"page":"217-222","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Retrospective Validation of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Criteria in a Developing Country"],"prefix":"10.4103","volume":"26","author":[{"given":"LH.","family":"Raffa","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia"},{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Bugshan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Aljuhani","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Alghoribi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Aljohani","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"B1-20240907","first-page":"Cd009734","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"1","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B2-20240907","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaapos.2012.09.004","article-title":"An update on progress and the changing epidemiology of causes of childhood blindness worldwide","volume":"16","author":"Kong","year":"2012","journal-title":"J aapos"},{"key":"B3-20240907","first-page":"233","article-title":"Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial","volume":"102","author":"Good","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"key":"B4-20240907","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0161-6420(91)32074-8","article-title":"Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"98","author":"Palmer","year":"1991","journal-title":"Ophthalmology"},{"key":"B5-20240907","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/bjo.2007.126508","article-title":"Retinopathy of prematurity in Saudi Arabia:Incidence, risk factors, and the applicability of current screening criteria","volume":"92","author":"Binkhathlan","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"B6-20240907","first-page":"211","article-title":"Incidence and risk factors of retinopathy of prematurity in a tertiary care newborn unit in New Delhi","volume":"9","author":"Maheshwari","year":"1996","journal-title":"Natl Med J India"},{"key":"B7-20240907","doi-asserted-by":"crossref","first-page":"e20183061","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"key":"B8-20240907","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamaophthalmol.2019.4517","article-title":"Validation of the postnatal growth and retinopathy of prematurity screening criteria","volume":"138","author":"Binenbaum","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"B9-20240907","doi-asserted-by":"crossref","first-page":"127","DOI":"10.18240\/ijo.2021.01.18","article-title":"Efficacy of the WINROP algorithm for retinopathy of prematurity screening in Southern China","volume":"14","author":"Bai","year":"2021","journal-title":"Int J Ophthalmol"},{"key":"B10-20240907","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamaophthalmol.2018.2753","article-title":"Development of modified screening criteria for retinopathy of prematurity:Primary results from the postnatal growth and retinopathy of prematurity study","volume":"136","author":"Binenbaum","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"B11-20240907","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jamaophthalmol.2017.2295","article-title":"Validation of the Children's hospital of philadelphia retinopathy of prematurity (CHOP ROP) model","volume":"135","author":"Binenbaum","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"B12-20240907","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13052-021-00991-z","article-title":"Using ROPScore and CHOP ROP for early prediction of retinopathy of prematurity in a Chinese population","volume":"47","author":"Sun","year":"2021","journal-title":"Ital J Pediatr"},{"key":"B13-20240907","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s13312-021-2321-4","article-title":"Diagnostic accuracy of WINROP, CHOP-ROP and ROPScore in detecting type 1 retinopathy of prematurity","volume":"58","author":"Thomas","year":"2021","journal-title":"Indian Pediatr"},{"key":"B14-20240907","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41372-020-0605-5","article-title":"Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the postnatal growth and ROP (G-ROP) study","volume":"40","author":"Zupancic","year":"2020","journal-title":"J Perinatol"},{"key":"B15-20240907","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clp.2013.02.003","article-title":"The challenge of screening for retinopathy of prematurity","volume":"40","author":"Wilson","year":"2013","journal-title":"Clin Perinatol"},{"key":"B16-20240907","doi-asserted-by":"crossref","first-page":"e013366","DOI":"10.1136\/bmjopen-2016-013366","article-title":"Treatment trends for retinopathy of prematurity in the UK:Active surveillance study of infants at risk","volume":"7","author":"Adams","year":"2017","journal-title":"BMJ Open"},{"key":"B17-20240907","doi-asserted-by":"crossref","first-page":"e186801","DOI":"10.1001\/jamanetworkopen.2018.6801","article-title":"Prevalence of severe visual disability among preterm children with retinopathy of prematurity and association with adherence to best practice guidelines","volume":"2","author":"Norman","year":"2019","journal-title":"JAMA Netw Open"},{"key":"B18-20240907","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/APO.0000000000000313","article-title":"Retinopathy of prematurity:How to prevent the third epidemics in developing countries","volume":"9","author":"Azad","year":"2020","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"B19-20240907","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1542\/peds.2004-1413","article-title":"The incidence and course of retinopathy of prematurity:Findings from the early treatment for retinopathy of prematurity study","volume":"116","author":"Good","year":"2005","journal-title":"Pediatrics"},{"key":"B20-20240907","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4103\/jfmpc.jfmpc_110_20","article-title":"Retinopathy of prematurity:Addressing the emerging burden in developing countries","volume":"9","author":"Senjam","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"B21-20240907","first-page":"261","article-title":"[Advances in Retinopathy of Prematurity","volume":"41","author":"Xu","year":"2019","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"B22-20240907","first-page":"11206721211011362","article-title":"Validation of the postnatal growth and retinopathy of prematurity screening criteria:A retrospective Italian analysis","author":"Caruggi","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"B23-20240907","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajo.2021.11.007","article-title":"Validation of the postnatal growth and retinopathy of prematurity screening criteria in a Taiwanese cohort","volume":"237","author":"Huang","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"B24-20240907","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajo.2019.03.027","article-title":"Retrospective validation of the postnatal growth and retinopathy of prematurity (G-ROP) criteria in a Japanese cohort","volume":"205","author":"Shiraki","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"B25-20240907","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12886-021-02227-4","article-title":"Retrospective validation of the postnatal growth and retinopathy of prematurity (G-ROP) criteria in a Swiss cohort","volume":"22","author":"Vinayahalingam","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"B26-20240907","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/09286586.2021.1939885","article-title":"The postnatal growth and retinopathy of prematurity model:A multi-institutional validation study","volume":"29","author":"Ahmed","year":"2022","journal-title":"Ophthalmic Epidemiol"},{"key":"B27-20240907","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s10792-020-01332-5","article-title":"Assessment of the G-ROP study criteria for predicting retinopathy of prematurity:Results from a tertiary centre in Turkey","volume":"40","author":"Yabas","year":"2020","journal-title":"Int Ophthalmol"},{"key":"B28-20240907","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1542\/peds.2005-2749","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"117","year":"2006","journal-title":"Pediatrics"},{"key":"B29-20240907","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity:Results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"B30-20240907","first-page":"720","article-title":"Retinopathy of prematurity at a University Hospital in Riyadh, Saudi Arabia","volume":"24","author":"Al-Amro","year":"2003","journal-title":"Saudi Med J"},{"key":"B31-20240907","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.2174\/1381612823666171002114545","article-title":"IGF-1 as a drug for preterm infants:A step-wise clinical development","volume":"23","author":"Hellstrom","year":"2017","journal-title":"Curr Pharm Des"},{"key":"B32-20240907","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/archophthalmol.2012.2524","article-title":"The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model","volume":"130","author":"Binenbaum","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"B33-20240907","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaapos.2015.10.017","article-title":"The Colorado-retinopathy of prematurity model (CO-ROP):Postnatal weight gain screening algorithm","volume":"20","author":"Cao","year":"2016","journal-title":"J AAPOS"},{"key":"B34-20240907","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archophthalmol.2009.69","article-title":"Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I","volume":"127","author":"L\u00f6fqvist","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"B35-20240907","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development:Implications for screening programs","volume":"115","author":"Gilbert","year":"2005","journal-title":"Pediatrics"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_523_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:04:34Z","timestamp":1787760274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_523_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_523_22","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"2022-08-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}